Skip to main content
IRRAS logo

IRRAS — Investor Relations & Filings

Ticker · IRRAS ISIN · SE0008321202 LEI · 549300EKKVQN2J25MJ59 ST Manufacturing
Open in API
Filings indexed 130 across all filing types
Latest filing 2023-08-04 Capital/Financing Update
Country SE Sweden
Listing ST IRRAS

About IRRAS

https://irras.com/

IRRAS is a commercial-stage medical technology company focused on designing, developing, and commercializing innovative solutions for neurocritical care. The company's core technology addresses challenges in fluid control and management for critically ill patients, particularly those with intracranial bleeding. Its primary product, the IRRAflow system, is an intelligent fluid management device that combines controlled irrigation with drainage to manage fluids and monitor intracranial pressure. The system is designed to improve patient outcomes, reduce complications, and decrease the overall cost of care by providing a new standard for treating brain pathologies.

Recent filings

Filing Released Lang Actions
IRRAS Secures Extended Short-Term Loan Agreement
Capital/Financing Update Classification · 1% confidence The document is an announcement regarding the extension and increase of a short-term loan facility between IRRAS AB and Bacara Holdings. It details the loan amount, interest rate, maturity date, and collateral terms. This falls under the category of company fundraising and financing activities.
2023-08-04 English
Uttalande från den oberoende budkommittén i IRRAS med anledning av uppköpserbjudandet från IR Holding Bidco
M&A Activity Classification · 1% confidence The document is a formal letter dated July 23, 2023, addressed to the independent committee of IRRAS AB (publ). The content explicitly states that Grant Thornton Sweden AB has been commissioned by this committee to act as an independent expert to assess the fairness of a public takeover offer (Erbjudandet) from a financial perspective for the shareholders. This type of expert opinion, often referred to as a fairness opinion, is typically prepared in the context of a takeover bid or merger proposal. Among the provided definitions, 'M&A Activity (Code: TAR)' covers merger proposals or takeover bids. While this is an expert report, its entire purpose is tied directly to the takeover bid, making TAR the most appropriate classification over a general Audit Report (AR) or Investor Presentation (IP).
2023-07-23 Swedish
Statement from the Independent Bid Committee of IRRAS regarding the public offer from IR Holding Bidco
M&A Activity Classification · 1% confidence The document is an opinion letter from Grant Thornton Sweden AB, acting as an independent expert, assessing the fairness of a public offer (takeover bid) made by the 'Bid Consortium' for IRRAS AB. The core content is a formal 'fairness opinion' regarding a takeover proposal. This directly relates to merger and acquisition activity. Therefore, the most appropriate classification is M&A Activity (TAR). It is not a full Annual Report (10-K), an Earnings Release (ER), or a general Audit Report (AR), but a specific report related to a takeover bid.
2023-07-23 English
Comment from the Independent Bid Committee of IRRAS regarding the public offer from IR Holding Bidco
M&A Activity Classification · 1% confidence The document discusses a public offer (takeover bid) for IRRAS AB by IR Holding Bidco Inc. It details the offer price, the involvement of board members, the expected timeline for the offer document, and the role of the Independent Bid Committee and its advisors (Carnegie, Setterwalls, Grant Thornton). This content directly relates to a merger or takeover proposal. Therefore, the most appropriate classification is M&A Activity (TAR). It is not a general regulatory filing (RNS) because it is highly specific to a takeover bid, nor is it an Earnings Release (ER) or Interim Report (IR), although it mentions the IR will be published later.
2023-06-30 English
IRRAS Shifts Commercial Strategy to Focus Resources on United States Market Opportunity and Publishes Financial Update
Earnings Release Classification · 1% confidence The document is titled with an announcement regarding a strategic shift and the publication of a 'Financial Update'. It contains specific financial figures for a recent period (April 1 - May 31, 2023), estimates for Q2 net sales, details about restructuring costs, and commentary from the CEO on business performance and outlook. This content structure—announcing key results, providing brief financial tables, and discussing strategy/outlook—is characteristic of an Earnings Release (ER). It is not a full Annual Report (10-K) or a comprehensive Interim Report (IR), as it focuses on highlights and operational changes rather than a complete set of audited statements. The final paragraph mentions the information is subject to EU Market Abuse Regulation, confirming it is a mandatory disclosure, but the content itself aligns best with an ER. Q2 2023
2023-06-29 English
IRRAS ändrar kommersiell strategi för att fokusera resurser på marknadsmöjligheter i USA samt publicerar finansiell uppdatering
Earnings Release Classification · 1% confidence The document is a press release from IRRAS AB dated June 29, 2023. It announces a strategic shift to focus resources on the US market and includes a 'financial update' with estimated net sales for the period April 1 to May 31, 2023, and commentary on restructuring costs and savings. This structure—announcing key financial figures for a recent period (Q2 update) alongside significant business strategy changes—is characteristic of an Earnings Release (ER) or potentially an Interim Report (IR) if it were more comprehensive. However, since it only provides estimates for a partial period (April-May) and focuses on key highlights and strategic decisions rather than a full set of mandated financial statements, it aligns best with an Earnings Release (ER). The final sentence mentions the information is disclosed under EU Market Abuse Regulation, confirming it is a formal regulatory announcement, but the content points specifically to financial results highlights. Q2 2023
2023-06-29 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.